We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Schroder Uk Public Private Trust Plc | LSE:SUPP | London | Ordinary Share | GB00BVG1CF25 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 14.725 | 14.25 | 15.20 | - | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
09/5/2022 21:53 | First ever (I think) buyback today. Only 50,000 shares but its a start and a message | scrapheap | |
29/4/2022 15:33 | Can't recall what they bought at, but the one plus with the Tim/Roger, Tim/Ben stock-picking is that everything is tiny, relative to the IT size. Good job too. "Net asset value of the healthcare-dominated portfolio has slumped 31% while the UK stock market has gained 13%." Down 26% overall since Schroders started taking their fees from it. | spectoacc | |
29/4/2022 10:17 | And now 'just' 18% - how odd | scrapheap | |
29/4/2022 08:55 | Now up 33% | scrapheap | |
29/4/2022 08:49 | Another superb Tim pick - I've just closed on JMAT. | zimmie | |
29/4/2022 08:43 | How much have we got in JMAT - it's up 25% at the moment, almost recovered what they bought at (but not quite!) | scrapheap | |
29/4/2022 08:29 | Excitement at JMAT this morning.... is it the new holder at 5%+? | scrapheap | |
27/4/2022 11:36 | Nice uplift on Benevolent holding value - handy timing with Oxford Nanopore's price fall. | scrapheap | |
25/4/2022 17:51 | Its surprising really that an organisation of the strength of Schroders took on this toxic vehicle. Even they haven't managed to turn it around and its still only 1/3rd of its IPO NAV and 1/4th in share price terms year's after the Woodford dilemna and after a bubble in blue-sky technology stocks post-Covid. They did well to repay the debt though. Extremely patient Capital might have been a better name! Basically, its a share that has permanently destroyed its original capital and that was down to Woodford's lousy investment strategy. | topvest | |
25/4/2022 17:44 | Boris and I tended to agree on very little, the few interactions I had with him. Never dull, mind you, and more than pleasant. Sir John Templeton was at Balliol, by the way. As was Jim Rogers*. Other than that, I am sure the various Nobel prize winners and compatriots in science are better off sticking to things like, er, founding Oxford Nanopore. That might be why I know a little bit about it. *many others besides, but, for balance, that would include Nicola Horlick. Anything else on your mind? | chucko1 | |
25/4/2022 15:25 | You have tried "giving advice" for 3 years, including buying at 72p, 35p and an assortment of others, under either your own name or that of Aliases. Many readers/posters on this BB sold or avoided, praise be to their Gods. I actually shorted when you bought. Advice - buy SLFX and make back some of your money. At 24.5p, you have clearly lost money unless you multiplied your capital invested in WPCT by a very (extremely) high factor at 22p (the low to buy). Of course. You are clearly both a liar and a charlatan. | chucko1 | |
25/4/2022 13:28 | If "success" means merely hanging on to avoid bankruptcy, it's not a great calling. | chucko1 | |
25/4/2022 07:25 | "topvest, you were the twit-troll who predicted three years in a row that WPCT/SUPP would go bust that year. Wrong,of course. You know nothing about investment. It would be better if you shut your big mouth......" ++++++++++ If one were to consider the difference between "bust" and the performance of SUPP the past three years, I see more difference between two ants in the Sahara. Even more so as viewed from the pyramidic heights of most other financial asset performance over the same time. I am sure his (Topvest's) scepticism was appreciated by many at the time. Avoidance of capital loss, which was substantial, is as most appreciate, one of the great Buffetisms. | chucko1 | |
25/4/2022 06:48 | Rutherford was written down to £21.3m in the latest results... | scrapheap | |
23/4/2022 21:00 | topvest, you were the twit-troll who predicted three years in a row that WPCT/SUPP would go bust that year. Wrong,of course. You know nothing about investment. It would be better if you shut your big mouth...... | johnwig | |
23/4/2022 17:56 | The portfolio is still over valued in my view. Rutherford Health is a prime example - £34m valuation ascribed to an investment that they say this on.... "In April 2022, Rutherford secured commitments from the Company and other shareholders for new funding at an amount of £4.5 million. The funding was provided to Rutherford in order to extend its runway while Rutherford is in the process of securing long-term funding. Should Rutherford’s efforts to secure long-term funding prove unsuccessful, there is a material risk that the company will need to file for administration." Surely, that's a valuation write-down of c£30m coming sometime soon. The 3 bigger valuations all look blue-sky speculations as well of little real intrinsic value. Call me old fashioned! | topvest | |
23/4/2022 09:03 | zimmie, Thanks for viewpoint. Mine is pure guesswork! Acacia are already under the 3% reporting threshold. 3% is approx 25m shares. I keep a manual record of daily volume [inc late reported trades that do not make it into the volume count on most charting software]. This is approaching 37 million since the lock up expired. At current volumes, over and above average daily churn, we probably have another month worth of selling to shift this lot. Longer if SUPP are also selling. There seems a lot of support for ONT around 350. II's will do much better by holding on, and selling into strength at some point in the future. For info I hold ONT and IPO, no holding in SUPP. gla | bamboo2 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions